Mayne Pharma | MYX - Capital De Empréstimo

Preço das Ações
2.20
Mudança Diária
0.07 3.29%
Mensal
-15.71%
Anual
-69.57%
Q1 Previsão
2.15




Capital De Empréstimo Alterar Data
Ansell USD 751.6M 113.1M 2025-12
Avita Medical AUD 42.24M 1.25M 2024-12
Cochlear AUD 200M 6.5M 2025-12
CSL USD 10.42B 273M 2025-12
Healius AUD 1.22B 103M 2024-12
Integral Diagnostics AUD 341.63M 1.98M 2024-06
Medical Developments International AUD 1.5M 167K 2025-12
Nanosonics AUD 3.21M 1.06M 2025-12
Polynovo AUD 15.39M 663K 2025-12
Ramsay Health Care AUD 11.2B 5.74B 2025-12
ResMed USD 403.92M 4.74M 2025-12
Sigma Healthcare AUD 1.88B 1.75B 2025-12
Sonic Healthcare AUD 4.19B 333.39M 2024-12
Telix Pharmaceuticals AUD 448.45M 76.97M 2025-12